S.Biomedics Co., Ltd. (KOSDAQ: 304360)

S.Biomedics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,892	1,410	4,066	6,131	9,188	3,426
Short-Term Investments	3,377	8,175	2,346	6,750	3,000	2,010
Trading Asset Securities	1,597	1,073	1,007	-	259.94	10,157
Cash & Short-Term Investments	13,866	10,658	7,419	12,881	12,448	15,593
Cash Growth	-10.10%	43.66%	-42.41%	3.48%	-20.17%	-3.22%
Accounts Receivable	1,549	1,922	1,246	388.8	713.77	779.5
Other Receivables	-	198.83	204.02	67.26	65.95	82.84
Receivables	1,549	2,211	1,540	456.07	789.71	862.34
Inventory	3,179	2,369	1,570	763.73	707.72	616.54
Prepaid Expenses	-	336.37	426	174.46	254.73	267.01
Other Current Assets	454.17	126.94	245.98	66.43	121.3	94.79
Total Current Assets	19,049	15,700	11,201	14,342	14,322	17,433
Property, Plant & Equipment	4,047	4,962	2,765	3,051	3,357	4,489
Long-Term Investments	500	1,533	1,000	0.06	0.04	0.02
Other Intangible Assets	92.75	118.78	153.76	25.44	19.32	16.85
Long-Term Deferred Tax Assets	343.07	358.55	412.76	-	-	-
Other Long-Term Assets	11,075	9,275	8,825	377.05	366.79	344.28
Total Assets	35,107	31,947	24,358	17,796	18,065	22,283
Accounts Payable	244.3	479.48	416.17	36.31	505.44	579.12
Accrued Expenses	0.19	294.48	253.98	182.96	138.66	94.87
Short-Term Debt	3,481	3,547	5,807	1,916	3,231	2,319
Current Portion of Long-Term Debt	345.93	338.51	331.66	96.02	88.94	91.12
Current Portion of Leases	906.79	804.99	442.6	492.23	441.04	441.76
Current Income Taxes Payable	11.74	39.1	13.46	-	-	-
Current Unearned Revenue	4.17	4.32	4.28	7.53	7.58	191.93
Other Current Liabilities	1,930	2,223	4,562	1,444	2,350	1,829
Total Current Liabilities	6,924	7,731	11,831	4,175	6,763	5,547
Long-Term Debt	6,300	6,480	7,008	3,783	1,392	798.3
Long-Term Leases	392.83	824.86	206.79	520.66	449.83	867.93
Long-Term Unearned Revenue	2,047	2,050	2,054	2,058	2,062	1,067
Other Long-Term Liabilities	964.22	932.98	622.38	2,058	1,480	441.49
Total Liabilities	18,629	19,672	23,323	13,964	13,265	9,544
Common Stock	5,873	5,669	5,110	5,110	5,075	1,251
Additional Paid-In Capital	72,244	61,926	44,478	44,478	43,936	46,748
Retained Earnings	-73,005	-65,472	-57,759	-51,485	-45,844	-38,106
Comprehensive Income & Other	5,339	4,809	4,393	4,408	2,649	3,107
Total Common Equity	10,452	6,932	-3,779	2,510	5,816	12,999
Minority Interest	6,027	5,343	4,814	1,321	-1,017	-260.27
Shareholders' Equity	16,478	12,275	1,035	3,832	4,800	12,739
Total Liabilities & Equity	35,107	31,947	24,358	17,796	18,065	22,283
Total Debt	11,426	11,995	13,796	6,808	5,602	4,518
Net Cash (Debt)	2,440	-1,337	-6,377	6,073	6,846	11,074
Net Cash Growth	-3.58%	-	-	-11.29%	-38.18%	-13.77%
Net Cash Per Share	214.04	-122.35	-624.02	598.26	677.20	1138.55
Filing Date Shares Outstanding	11.75	11.34	10.22	10.22	10.15	2.5
Total Common Shares Outstanding	11.75	11.34	10.22	10.22	10.15	2.5
Working Capital	12,125	7,969	-629.62	10,167	7,559	11,886
Book Value Per Share	889.82	611.43	-369.73	245.64	573.05	5194.69
Tangible Book Value	10,359	6,813	-3,932	2,485	5,797	12,983
Tangible Book Value Per Share	881.92	600.95	-384.77	243.15	571.15	5187.96
Land	241.82	241.82	241.82	117.16	117.16	117.16
Buildings	558.2	558.2	558.2	349.29	349.29	349.29
Machinery	6,163	6,061	4,849	4,552	4,091	3,840
Construction In Progress	609	829.26	441.24	42.5	5.4	2.9

Source: S&P Capital IQ. Standard template. Financial Sources.